Unknown

Dataset Information

Optimising the mutation screening strategy in Marfan syndrome and identifying genotypes with more severe aortic involvement.


ABSTRACT:

Background

Marfan syndrome (MFS) is a systemic connective tissue disorder with life-threatening manifestations affecting the ascending aorta. MFS is caused by dominant negative (DN) and haploinsufficient (HI) mutations of the FBN1 gene. Our aim was to identify mutations of MFS patients with high detection rate and to investigate the use of a gene panel for patients with Marfanoid habitus. We also aimed to examine correlations between genotype and cardiovascular manifestations to predict "malignant" mutations.

Methods

136 individuals were enrolled. In the first phase, next-generation sequencing (NGS) and Sanger sequencing were performed for 57 patients to screen the FBN1 gene, followed by multiplex ligation-dependent probe amplification (MLPA) in negative cases. For repeated

SUBMITTER: Stengl R 

PROVIDER: S-EPMC7558671 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature